key: cord-0868742-yp4gq14k
authors: Wellehan Jr., James F.X.; Green, Linda G.; Duke, Diane G.; Bootorabi, Shadi; Heard, Darryl J.; Klein, Paul A.; Jacobson, Elliott R.
title: Detection of specific antibody responses to vaccination in variable flying foxes (Pteropus hypomelanus)
date: 2009-09-30
journal: Comparative Immunology, Microbiology and Infectious Diseases
DOI: 10.1016/j.cimid.2007.11.002
sha: 212dfe1a12b32566812b27351b9629550ea26644
doc_id: 868742
cord_uid: yp4gq14k

Abstract Megachiropteran bats are biologically important both as endangered species and reservoirs for emerging human pathogens. Reliable detection of antibodies to specific pathogens in bats is thus epidemiologically critical. Eight variable flying foxes (Pteropus hypomelanus) were immunized with 2,4-dinitrophenylated bovine serum albumin (DNP-BSA). Each bat received monthly inoculations for 2 months. Affinity-purified IgG was used for production of polyclonal and monoclonal anti-variable flying fox IgG antibodies. ELISA and western blot analysis were used to monitor immune responses and for assessment of polyclonal and monoclonal antibody species cross-reactivity. Protein G, polyclonal antibodies, and monoclonal antibodies detected specific anti-DNP antibody responses in immunized variable flying foxes, with protein G being the most sensitive, followed by monoclonal antibodies and then polyclonal antibodies. While the polyclonal antibody was found to cross-react well against IgG of all bat species tested, some non-specific background was observed. The monoclonal antibody was found to cross-react well against IgG of six other species in the genus Pteropus and to cross-react less strongly against IgG from Eidolon helvum or Phyllostomus hastatus. Protein G distinguished best between vaccinated and unvaccinated bats, and these results validate the use of protein G for detection of bat IgG. Monoclonal antibodies developed in this study recognized immunoglobulins from other members of the genus Pteropus well, and may be useful in applications where specific detection of Pteropus IgG is needed.

Detection of specific antibody responses to vaccination in variable flying foxes (Pteropus hypomelanus)

Bats are the second largest mammalian order, Chiroptera, with approximately 1100 species [1] . The variable flying fox, Pteropus hypomelanus, is a megachiropteran bat that inhabits Sulawesi and small islands from the Bay of Bengal and the Malay Peninsula to New Guinea and the Solomon Islands. The range of this species is fragmented, and rapid habitat destruction is occurring throughout the range. Since 1989, it has been listed as CITES appendix II. There are seven subspecies of this bat, the most endangered being P. hypomelanus maris, found on the Maldives [2] . The greatest threat to the variable flying fox is human predation and habitat destruction. This bat is heavily hunted and is exported for food in the Philippines. Residents of Guam have imported large numbers of Pteropus spp. from other Pacific islands as a delicacy. Thirty-four percent of megachiropteran bats are at risk of extinction [3] , and all members of the genus Pteropus are listed as at least CITES appendix II.

It is not surprising to find significant pathogen diversity in bats. There are over 900 bat species, representing approximately 20% of mammalian diversity [4] . While less than 2% of human pathogens have bats as natural reservoirs, several emerging potentially lethal viral infections of humans have recently been found in wild flying fox populations, attracting significant interest [4] . These include Nipah virus, Menangle virus, Hendra virus, and Australian bat lyssavirus. Evidence suggests that megachiropteran bats are carriers of Ebola virus [5] , and Rhinolophid bats, which are closely related to the megachiropterans, are carriers of SARS-like coronaviruses [1, 6, 7] . With the subsequent interest in viruses of bats, Tioman virus has recently been discovered [8] , and it is likely that further bat viruses will be discovered in the near future. Evidence for Nipah virus [9] , Tioman virus, and Australian bat lyssavirus [10] have been found in wild P. hypomelanus. Currently, serum neutralization assays are the most common tests used to detect the presence of antibodies to specific pathogens in bats, and are accepted as the reference standard [11] . However, serum neutralization assays require days to weeks for results, and require virus culture, which is labor intensive, slow, and involves live virus culture, representing a risk to personnel. IgG assays have also been performed in bats using chimeric protein G, a streptococcal protein, and protein A, a staphylococcal protein, that bind IgG from a number of different species [11] [12] [13] . Assays have also been performed using only protein G [7, 14] . Protein A and protein G do not bind well to immunoglobulins from all species [15] . Protein A has been found not to bind well to immunoglobulins from some bat species [16] . The specificity and avidity of either protein G or chimeric protein G/protein A for bat immunogobulins has not been published.

There is not only a need to rapidly assess wild populations for emerging bat and human pathogens but also a need to establish healthy specific pathogen free captive populations of fruit bats. While transmission studies may result in the death of the animal being challenged, immunization studies are rather benign, having minimal affect on the host other than inducing an immune response. This is an important concern when working with threatened species. This project used an immunization study to develop and validate the reagents needed for developing ELISAs for the variable flying fox. These reagents and the information generated will prove useful for seroepidemiological studies of Pteropus spp.

Eight adult (4 male, 4 female) variable flying foxes (P. hypomelanus) housed at the Lubee Bat Conservancy in Gainesville, Florida were used in this study. All were assessed as healthy before inclusion in the study based on physical examination and blood values within reference ranges for this species. This protocol was approved by the University of Florida Institutional Animal Care and Use Committee. Blood samples (2 ml) were collected from the brachial vein and placed into lithium heparin tubes on days 0, 28, and 56.

Following blood collection on days 0 and 28, six bats (3 male, 3 female) were immunized by subcutaneous and intramuscular inoculation with 250 mg (500 ml; 1/2 SQ-1/2 IM) conjugated 2,4-dinitrophenylated bovine serum albumin (DNP-BSA) (Molecular Probes, Eugene, OR) in a monophosphoryl lipid A plus synthetic trehalose dimycolate (MPL + TDM) adjuvant system (Sigma Chemical Co., St. Louis, MO). Two bats (1 male, 1 female) were immunized by subcutaneous and intramuscular inoculation with phosphate-buffered saline (PBS) in MPL + TDM adjuvant as negative controls. Plasma was obtained by low speed centrifugation of the tubes at 300 Â g for 10 min at room temperature. All plasma samples were stored at À70 8C.

To determine the best reagent for purification of P. hypomelanus immunoglobulin, an ELISA looking for binding of anti-IgG reagents to P. hypomelanus plasma was performed. Ninety-six well plates (Nunc Maxisorp, Fisher Scientific, Pittsburgh, PA) were coated with DNP-BSA overnight at 4 8C. Positive control wells were coated with serum appropriate for the secondary antibody. Wells were washed with PBS containing 0.02% sodium azide and 0.05% Tween-20 using a microplate washer (Biotek Instruments, Winooski, VT). A 1:100 dilution of immunized bat serum in PBS containing 0.02% sodium azide (PBS-AZ) was added. Negative control wells were incubated with PBS-AZ only. The plates were incubated at room temperature for 1 h. The plates were washed, and various secondary alkaline phosphatase-conjugated anti-immunoglobulin reagents were added (rabbit anti- Plates were incubated at room temperature for 1 h. After incubation and washing, each well received 0.1 ml of alkaline phosphatase substrate (1 mg/ml p-nitrophenyl phosphate, Sigma Chemical Co.). Color development was monitored visually, and the absorbance at 405 nm (OD 405 ) was recorded after 30 and 60 min by use of a microplate reader (Spectramax 250, Molecular Devices, Sunnyvale, CA).

Purification of P. hypomelanus immunoglobulin was performed using a commercial protein G column (HiTrap Protein G HP 5 ml, GE Healthcare, Piscataway, NJ). The column was prewashed with 50 ml PBS-AZ. A 0.5 ml aliquot of P. hypomelanus plasma was diluted 1:5 in PBS-AZ and circulated over the column for 50 min. The column was washed with 65 ml of PBS-AZ. IgG was eluted from the column using 0.1 M glycine, pH 3.0. Fractions were collected in 3.0 ml aliquots as they eluted from the column. Absorbance at 280 nm of each fraction was measured, and peak fractions were pooled. The eluate was desalted using a centrifugal filter device (Ultrafree, Millipore, Billerca, MA 01821) with a 30 kDa cut-off. The eluted protein was electrophoresed (2100 Bioanalyzer, Agilent Technologies, Palo Alto, CA) and measured.

Purified P. hypomelanus IgG was delivered to a private biological company (Strategic Biosolutions, Newark, DE) for polyclonal antiserum production. Two rabbits were immunized using their standard protocol. Plasma samples were obtained from each rabbit before immunization (preimmune plasma). Rabbits were immunized with 200 mg of P. hypomelanus IgG with complete Freund's adjuvant (first injection), then with incomplete Freund's adjuvant (all subsequent injections). Inoculations were given on days 0, 21, 35, and 49, and plasma samples were obtained on days 42, 57 and 63. Rabbits were anesthetized and exsanguinated on day 89. Serum samples were stored at À70 8C.

Mouse monoclonal antibodies against P. hypomelanus IgG were produced by standard protocols used by the Interdisciplinary Center for Biotechnology Research Hybridoma Core Laboratory at the University of Florida [17] . Briefly, a Balb/c female mouse was immunized subcutaneously with 30 mg of P. hypomelanus IgG in MPL + TDM adjuvant. Immunization was repeated on days 17, 92, and 143. Serum samples were obtained from the tail vein on days 27 and 103. The mouse was euthanatized and the spleen was harvested. Spleen cells from the immunized mice were fused with Sp2/0 mouse myeloma cells at a ratio of 7:1 using 50% polyethylene glycol. Supernatants from the resulting hypoxanthine/ aminopterine/thymidine (HAT) resistant hybridoma cells were evaluated for the presence of antibody that bound to P. hypomelanus IgG by ELISA using methods similar to those described above, with P. hypomelanus IgG-coated wells and alkaline phosphatase labeled rabbit anti-mouse IgG (A-1902) as a secondary antibody. Hybridomas from wells with positive antibody results (OD 405 3-20Â over background) were transferred to 24 well plates and screened by an ELISA a second time. One hybridoma with positive antibody results was selected and cloned. The cloned hybridoma cell line was designated HL1892.

ELISAs were used to monitor the humoral immune response to DNP-BSA in variable flying foxes. Wells of a high protein binding microplate (Nunc Maxisorp, Fisher Scientific) were coated with 50 ml of DNP-BSA (1.0 mg/ml) and were left to adsorb overnight at 4 8C. After this and each subsequent step, all wells were washed three times with PBS-AZ and 0.05% Tween-20 using an automated microplate washer. After washing, all wells were blocked with PBS-AZ containing 5% nonfat dry milk (NFDM). This and each subsequent step of the ELISA were incubated with gentle agitation for 1 h at approximately 25 8C. Variable flying fox plasma samples were diluted from 1:25 to 1:32,000, and replicate wells were done for each dilution. PBS-AZ was applied to a pair of wells for each plasma sample to serve as duplicate negative control wells. Fifty microliter of preimmune and immune bat plasma dilutions were used to coat the wells. Alkaline phosphatase-conjugated protein G (1:500 in PBS-AZ), rabbit anti-P. hypomelanus IgG polyclonal antibody (1:10,000 in PBS-AZ), and mouse anti-P. hypomelanus IgG monoclonal antibody (undiluted hybridoma supernatant) were added for the detection of bound bat antibodies. Alkaline phosphataseconjugated goat anti-rabbit IgG (Sigma A-8025, 1:2000 in PBS-AZ) and rabbit anti-mouse IgG (A-1902, 1:1000 in PBS-AZ) were used as secondary antibodies for polyclonal or monoclonal antibodies, respectively. After washing, 0.1 ml of 1 mg/ml p-nitrophenyl phosphate was added for detection. Color development was monitored visually, and the OD 405 was recorded after 30 and 60 min by use of a microplate reader. For analysis, the average OD 405 of the negative controls were subtracted from the average OD 405 readings of all other wells of the corresponding antibody (corrected OD 405 ).

For further evaluation of the specificity of the polyclonal and monoclonal antibodies, variable flying fox plasma was separated by gel electrophoresis in SDS-PAGE under reducing conditions using pre-cast 10% Bis-Tris gels (Invitrogen, San Diego, CA) and then electrophoretically transferred from the gel to a nitrocellulose membrane (Invitrogen). A Tris-glycine buffer (Invitrogen) in 20% methanol was used as the transfer buffer. The blotting time was 60 min at 30 V. After transfer, the nitrocellulose was immediately blocked overnight with PBS-AZ containing 5% NFDM at room temperature (approximately 25 8C). The nitrocellulose blot was washed three times for 5 min each with PBS solution containing 0.02% sodium azide and 0.05% Tween-20 and placed into a channel divider (Fast Blot Developer, Pierce, Rockford, IL). The rabbit polyclonal antisera was diluted 1:50,000. A 1:50,000 dilution of rabbit preimmune sera was used as a negative control. A total of 900 ml of primary antibody (polyclonal or monoclonal antibodies) was loaded into each channel and incubated on the nitrocellulose for 60 min at room temperature on a rocker. After washing, the nitrocellulose was removed from the manifold and incubated with the appropriate secondary antibody: alkaline phosphatase labeled goat anti-rabbit IgG (diluted 1:2000 in PBS-AZ) or goat anti-mouse IgG (diluted 1:4000 in PBS-AZ) for the polyclonal antibody and monoclonal antibodies, respectively, for 60 min. After washing, the blot was developed with nitroblue tetrazolium 5-bromo-4chloro-3 inolyphosphate p-toluidine substrate, per manufacturer's instructions (Sigma Chemical Co.).

The ability of the rabbit polyclonal antibody and monoclonal antibody HL1892 to crossreact with previously banked plasma from eight bat species, including six other species in the genus Pteropus (P. conspicillatus, P. giganteus, P. poliocephalus, P. pumilus, P. rodricensis, and P. vampyrus), another megachiropteran species (Eidolon helvum), and a phyllostomatid microchiropteran (Phyllostomus hastatus), was evaluated by an ELISA as described above. Wells were coated with 50 ml of a 1:100 dilution of plasma samples from each of the eight bat species. Fifty microliter of a 1:5000 dilution of rabbit polyclonal anti-P. hypomelanus IgG or undiluted mouse monoclonal anti-P. hypomelanus IgG hybridoma supernatant was then evaluated for reactivity on these plasma samples. A 1:5000 dilution of rabbit preimmune sera was used as a negative control for the polyclonal antibody ELISA, and hybridoma culture media was used as a negative control for the monoclonal antibody ELISA. Appropriate secondary antibodies were used as described above. The polyclonal antibody ELISA was read at 30 min and the monoclonal antibody ELISA was read at 60 min. For analysis, the average OD 405 of the negative controls were subtracted from the average OD 405 readings of all other wells of the corresponding antibody (corrected OD 405 ). Specificity of this reaction was confirmed by western blot analysis as described above using serum from the different bat species.

At 60 min, a 33-fold increase in absorbance over the negative control was seen using a 1:1000 dilution of alkaline phosphatase-conjugated protein G. At 60 min, a 10-fold increase over the negative control was seen using a 1:1000 dilution of goat anti-human IgGlambda chain specific. These wells were detected with a rabbit anti-goat IgG alkaline phosphatase conjugate. Significant increase was not seen with other anti-immunoglobulin antibodies. A protein G column was therefore used for purification of P. hypomelanus IgG.

The protein eluted from the protein G column measured 161 kDa unreduced and had two bands of 58.1 and 28.7 kDa when reduced (Fig. 1) . This was comparable in size to mouse IgG, which measured 154.9 kDa unreduced and had two bands of 56.4 and 21.5 kDa when reduced on the same equipment. In other reports, bat IgGs were comparably sized [18, 19] .

Immunized variable flying foxes developed an anti-DNP-BSA titer compared with preimmune plasma. Use of protein G in an ELISA showed the greatest increase in antibody titer between pre-vaccination and 56 day post-vaccination variable flying fox plasma with samples diluted 1:2000 in PBS (Fig. 2) . Detection of the anti-DNP-BSA antibody titer by use of the polyclonal rabbit anti-P. hypomelanus IgG antibody showed the greatest increase in increase in antibody titer between pre-vaccination and 56 day post-vaccination variable flying fox plasma samples diluted 1:800 (Fig. 3) . Detection of the anti-DNP-BSA antibody titer by use of the monoclonal mouse anti-P. hypomelanus IgG antibody HL1892 showed the greatest increase in antibody titer between pre-vaccination and 56 day post-vaccination variable flying fox plasma samples diluted 1:100 (Fig. 4) . Bats A and E consistently showed strong antibody responses to DNP-BSA in all assays, whereas bat B showed little to no antibody response to vaccination.

Western blot reactivity of anti-P. hypomelanus IgG's on variable flying fox plasma was determined (Fig. 5) . The polyclonal antibody (lane 1) reacted with major bands at approximately 58 and 29 kDa, consistent with IgG heavy chain and light chain, respectively. Multiple weaker bands ranging from >191 to 15 kDa were also seen, and were interpreted as non-specific binding. Monoclonal antibody HL1892 (lane 2) reacted with a band at approximately 58 kDa, consistent with IgG heavy chain. Non-specific binding was not seen under the conditions used. No reaction was seen with the negative control (lane 3).

The polyclonal anti-P. hypomelanus IgG antibody was found to cross-react well against plasma of all bat species tested by ELISA, although more strongly with bats in the genus Pteropus (Table 1 ). The monoclonal antibody HL1892 was found to cross-react by ELISA equally as well against plasma of P. poliocephalus and P. pumilus as it did against P. hypomelanus plasma. Strong reaction was also seen with plasma from other members of the genus Pteropus tested, with OD 405 readings 49-70% of those seen against P. hypomelanus plasma. OD 405 readings against plasma from E. helvum or P. hastatus were not significantly different from that seen with negative controls. On western blot using the anti-P. hypomelanus IgG polyclonal antibody for detection, major bands were detected at approximately 58 and 29 kDa with all bat plasma tested, consistent with IgG heavy chain and light chain, respectively (Fig. 6) . Cross-reaction with some non-specific background similar to that seen with P. hypomelanus plasma was seen for all bat sera tested. Monoclonal antibody HL1892 (Fig. 7) reacted with a band at approximately 58 kDa in all bat plasma, consistent with IgG heavy chain. Non-specific binding was not seen under the conditions used. No reaction was seen with the negative control (data not shown). 

The reagents used in this study may be useful for the development of ELISA and western blot tests for antibodies to pathogens found in Pteropus spp. Although neutralization assays are accepted as the reference standard [11] , there are several disadvantages to these assays. Serum neutralization requires a period of days to weeks to obtain results, and early diagnosis of infection may be important for epidemiologic control. Serum neutralization assays also require pathogen culture, and as some emerging infections of bats represent serious biohazards, the risk to personnel is significant, and appropriate facilities for culture are limited. Serum neutralization also needs consistent CPE, and some viruses may have limited CPE. In addition to serum neutralization, several other methods have been used for the detection of antibodies in bats, including hemagglutination inhibition [20] , complement fixation [21] , and gel immunoprecipitation [22] .

Early work showed that in big brown bats (Eptesicus fuscus) experimentally infected with Japanese encephalitis virus, the predominant antibody type shifted from a heavier protein (corresponding to IgM) to a lighter protein (corresponding to IgG) within 20 days [23] . A study using bacteriophage øX174 as an antigen in big brown bats found that vaccinated animals had converted to an IgG response by 8 weeks [24] . Bats had high neutralizing antibody titers 3.5 years after vaccination. Great fruit-eating bats (Artibeus lituratus) were shown to develop strong IgM and IgA responses to experimental Histoplasma capsulatum infection at 3-5 weeks and IgG responses by 8-9 weeks [22] . Within the genus Pteropus, Indian flying foxes (P. giganteus) immunized with sheep erythrocytes had a maximal IgG response at 15-30 days, depending on immunization dose [25] . Vampire bats (Desmodus rotundus) orally vaccinated with a recombinant rabies vaccine showed the protection 18 days post-vaccination, with maximal protection 30 days post-vaccination [26] . Protection decreased at 90 and 120 days post-vaccination. Egyptian fruit bats (Rousettus aegyptiacus) vaccinated with a killed rabies vaccine developed neutralizing antibody titers [27] .

Previous ELISA assays have been used in bats. ELISAs using a chimeric protein A/G as conjugate have been used for the detection of antibodies to Nipah and Hendra viruses in bats, and an ELISA using this protocol has been found to have a specificity of 98.4% for Nipah virus in pigs [11] . A similar ELISA was used to screen for lyssavirus in Cambodian bats [12] . In the lyssavirus study, ELISA-positive sera were confirmed using a neutralization assay, and only 27% had neutralizing antibodies. Reasons for this discrepancy may be either low specificity of the lyssavirus ELISA, low sensitivity of the neutralization assay, or detection of antibodies to non-neutralizing epitopes.

ELISA methods that do not require binding of the constant region of immunoglobulins have also been developed. These assays require pathogen-specific rather than host antibody-specific reagents. Competitive ELISA methods have been used to detect antibodies to Nipah virus in lesser short-nosed fruit bats (Cynopterus brachyotis) and common dawn bats (Eonycteris spelaea), two megachiropteran species [28] . A capture ELISA has been used for detection of Nipah and Hendra virus-specific IgM [11] .

It is important to remember that antibody assays only measure one aspect of the immune system, and cellular immune responses are likely to be more important for intracellular pathogens such as viruses. In a study on rabies vaccination in vampire bats, 31 of 32 bats were protected from challenge by vaccination, whereas 9 of 10 unvaccinated bats succumbed [29] . Of these 31 protected bats, 9 (29%) did not develop a neutralizing antibody titer, implying a large role for cellular immunity in protection. Absence of antibody does not demonstrate that an animal has not been exposed to a pathogen.

Control strategies for dealing with bat-borne diseases have primarily been centered on elimination of bat populations. This is unacceptable when applied to endangered species, and is likely to be less effective than vaccination strategies [29, 30] . There are currently no active immunization programs in wild bats [31] . Bats are fastidious groomers, and vampire bats have been shown to take up anticoagulants applied to the backs of conspecifics [26] . Oral rabies vaccines have been shown to be effective against challenge in vampire bats [26, 29, 32] . Oral subunit vaccines delivered via transgenic plants have been suggested [31] .

Polyclonal antibodies to IgG of another megachiropteran species, the Egyptian fruit bat (Rousettus aegyptiacus), have been made [18] . Based on their western blot results, their polyclonal antibodies appear to have a greater specificity for chiropteran IgG than the more broadly cross-reactive polyclonal antibodies developed in this study. Their antibodies were used to determine phylogeny by examining cross-reactivity with other species. This may be a future use for the antibodies developed in this study. Evidence is mounting that the phylogenetic division between the suborders Microchiroptera and Megachiroptera is a false dichotomy, and that microchiropterans are not monophyletic. Molecular sequence data suggests that Rhinolophoid bats actually cluster with Pteropodid bats, which were considered the sole family in the megachiroptera [1] . These bats have been classified into the Yinpterochiroptera, and the remaining microchiropterans classified into the Yangochiroptera. No Rhinolophoid bat sera were examined, so no conclusions can be drawn regarding cross-reactivity, but this may be a direction for further studies.

In conclusion, protein G, polyclonal anti-P. hypomelanus IgG, and monoclonal anti-P. hypomelanus IgG all detected specific anti-DNP-BSA antibody responses in immunized variable flying foxes. The polyclonal antibody was found to cross-react well against IgG of all bat species tested, but did not show as great a difference between vaccinated and unvaccinated bats. This was likely due to non-specific binding as seen on the western blot, resulting in high backgrounds. The monoclonal antibody was found to cross-react well against IgG of six other species in the genus Pteropus and to cross-react less strongly against IgG from E. helvum or P. hastatus. Protein G distinguished best between vaccinated and unvaccinated bats, and these results validate the use of protein G for detection of bat IgG antibodies. The monoclonal antibodies developed in this study recognized immunoglobulins from other members of the genus Pteropus well, and may be useful in applications where specific detection of Pteropus IgG is needed. Further investigation of these reagents in diagnostic assays is merited.

A molecular phylogeny for bats illuminates biogeography and the fossil record

Biological correlates of extinction risk in bats

What links bats to emerging infectious diseases?

Fruit bats as reservoirs of Ebola virus

Bats are natural reservoirs of SARS-like coronaviruses

Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats

Tioman virus, a novel paramyxovirus isolated from fruit bats in Malaysia

Isolation of Nipah virus from Malaysian Island flying-foxes

Serologic evidence of Lyssavirus infections among bats, the Philippines

Laboratory diagnosis of Nipah and Hendra virus infections

Serologic evidence of lyssavirus infection in bats

Recombinant fusion proteins of protein A and protein G with glutathione Stransferase as reporter molecules

Transmission studies of Hendra virus (equine morbillivirus) in fruit bats, horses, and cats

Protein G: a powerful tool for binding and detection of monoclonal and polyclonal antibodies

Rabies and bats in a rabies-endemic area of southern Africa: application of two commercial test kits for antigen and antibody detection

Antibody responses of tumor-bearing mice to their own tumors captured and perpetuated as hybridomas

Molecular evolution inferred from immunological cross-reactivity of immunoglobulin G among Chiroptera and closely related species

Rabies in a captive colony of big brown bats (Eptesicus fuscus)

Venezuelan encephalitis virus infection in neotropical bats. II. Experimental infections

Immune responses in bats following intranasal infection with Histoplasma capuslatum

Role of immunoglobulin classes in experimental histoplasmosis in bats

Bat immunoglobulins formed in response to experimental Japanese B encephalitis (JBE) virus infection

Studies on the immune capabilities of chiroptera. I. Quantitative and qualitative nature of the immune responses in bats to bacteriophage øX174

Antibody-mediated immune response in the bat, Pteropus giganteus

Experimental rabies vaccination and oral vaccination in vampire bats (Desmodus rotundus)

Vaccination of Egyptian fruit bats (Rousettus aegyptiacus) with monovalent inactivated rabies vaccine

A solid-phase blocking ELISA for detection of antibodies to Nipah virus

Vaccination of vampire bats using recombinant vaccinia-rabies virus

Haematophagous bats in Brazil, their role in rabies transmission, impact on public health, livestock industry, and alternatives to an indiscriminate reduction of bat population

Managing emerging diseases borne by fruit bats (flying foxes), with particular reference to henipaviruses and Australian bat lyssavirus

Indirect oral immunization of captive vampires, Desmodus rotundus

This project was funded by a grant from the Lubee Bat Conservancy, and is published as Lubee Bat Conservancy Publication #130. The authors would like to thank Dana LeBlanc, Pam Thomas, Allyson Walsh, and the rest of the staff at Lubee Bat Conservancy for their assistance. We would also like to thank Maud Lafortune for translation.